Literature DB >> 15090557

Applications of positron emission tomography (PET) in neurology.

Y F Tai1, P Piccini.   

Abstract

Positron emission tomography (PET) is a powerful imaging technique which enables in vivo examination of brain functions. It allows non-invasive quantification of cerebral blood flow, metabolism, and receptor binding. In the past PET has been employed mainly in the research setting due to the relatively high costs and complexity of the support infrastructure, such as cyclotrons, PET scanners, and radiochemistry laboratories. In recent years, because of advancements in technology and proliferation of PET scanners, PET is being increasingly used in clinical neurology to improve our understanding of disease pathogenesis, to aid with diagnosis, and to monitor disease progression and response to treatment. This article aims to provide an overview of the principles of PET and its applications to clinical neurology.

Mesh:

Substances:

Year:  2004        PMID: 15090557      PMCID: PMC1763584          DOI: 10.1136/jnnp.2003.028175

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  88 in total

1.  A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity.

Authors:  A O Ceballos-Baumann; H Boecker; P Bartenstein; I von Falkenhayn; H Riescher; B Conrad; J R Moringlane; F Alesch
Journal:  Arch Neurol       Date:  1999-08

2.  Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study.

Authors:  M Samuel; A O Ceballos-Baumann; N Turjanski; H Boecker; A Gorospe; G Linazasoro; A P Holmes; M R DeLong; J L Vitek; D G Thomas; N P Quinn; J A Obeso; D J Brooks
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

3.  In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis.

Authors:  M J Koepp; K S Hand; C Labbé; M P Richardson; W Van Paesschen; V H Baird; V J Cunningham; N G Bowery; D J Brooks; J S Duncan
Journal:  Ann Neurol       Date:  1998-05       Impact factor: 10.422

Review 4.  Parkinson's disease. First of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245

Review 5.  Positron emission tomography studies in movement disorders.

Authors:  D J Brooks
Journal:  Neurosurg Clin N Am       Date:  1998-04       Impact factor: 2.509

6.  Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.

Authors:  R N Gunn; A A Lammertsma; S P Hume; V J Cunningham
Journal:  Neuroimage       Date:  1997-11       Impact factor: 6.556

7.  Evidence for striatal dopamine release during a video game.

Authors:  M J Koepp; R N Gunn; A D Lawrence; V J Cunningham; A Dagher; T Jones; D J Brooks; C J Bench; P M Grasby
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

8.  PET scanning and the human immunodeficiency virus-positive patient.

Authors:  M J O'Doherty; S F Barrington; M Campbell; J Lowe; C S Bradbeer
Journal:  J Nucl Med       Date:  1997-10       Impact factor: 10.057

9.  Sequential bilateral transplantation in Parkinson's disease: effects of the second graft.

Authors:  P Hagell; A Schrag; P Piccini; M Jahanshahi; R Brown; S Rehncrona; H Widner; P Brundin; J C Rothwell; P Odin; G K Wenning; P Morrish; B Gustavii; A Björklund; D J Brooks; C D Marsden; N P Quinn; O Lindvall
Journal:  Brain       Date:  1999-06       Impact factor: 13.501

10.  Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients.

Authors:  P Ryvlin; S Bouvard; D Le Bars; G De Lamérie; M C Grégoire; P Kahane; J C Froment; F Mauguière
Journal:  Brain       Date:  1998-11       Impact factor: 13.501

View more
  17 in total

1.  PET and SPECT in psychiatry: the past and the future.

Authors:  Marco Pagani; Sara Carletto; Luca Ostacoli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09       Impact factor: 9.236

2.  PET image denoising using unsupervised deep learning.

Authors:  Jianan Cui; Kuang Gong; Ning Guo; Chenxi Wu; Xiaxia Meng; Kyungsang Kim; Kun Zheng; Zhifang Wu; Liping Fu; Baixuan Xu; Zhaohui Zhu; Jiahe Tian; Huafeng Liu; Quanzheng Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-29       Impact factor: 9.236

3.  Imaging Biological Pathways in Abdominal Aortic Aneurysms Using Positron Emission Tomography.

Authors:  Michael Bell; Richa Gandhi; Heba Shawer; Charalampos Tsoumpas; Marc A Bailey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-25       Impact factor: 8.311

4.  Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions.

Authors:  Eszter Császár; Nikolett Lénárt; Csaba Cserép; Zsuzsanna Környei; Rebeka Fekete; Balázs Pósfai; Diána Balázsfi; Balázs Hangya; Anett D Schwarcz; Eszter Szabadits; Dávid Szöllősi; Krisztián Szigeti; Domokos Máthé; Brian L West; Katalin Sviatkó; Ana Rita Brás; Jean-Charles Mariani; Andrea Kliewer; Zsolt Lenkei; László Hricisák; Zoltán Benyó; Mária Baranyi; Beáta Sperlágh; Ákos Menyhárt; Eszter Farkas; Ádám Dénes
Journal:  J Exp Med       Date:  2022-02-24       Impact factor: 14.307

5.  Mechanisms of unilateral STN-DBS in patients with Parkinson's disease : a PET study.

Authors:  Noritoshi Arai; Fusako Yokochi; Takashi Ohnishi; Toshimitsu Momose; Ryoichi Okiyama; Makoto Taniguchi; Hiroshi Takahashi; Hiroshi Matsuda; Yoshikazu Ugawa
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

Review 6.  Dosage optimization in positron emission tomography: state-of-the-art methods and future prospects.

Authors:  Nicolas A Karakatsanis; Eleni Fokou; Charalampos Tsoumpas
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

7.  Novel positron emission tomography radiotracers in brain tumor imaging.

Authors:  Maria Mathew D'Souza; Rajnish Sharma; Madhavi Tripathi; Puja Panwar; Abhinav Jaimini; Anupam Mondal
Journal:  Indian J Radiol Imaging       Date:  2011-07

8.  Recent progress of imaging agents for Parkinson's disease.

Authors:  Xiaoai Wu; Huawei Cai; Ran Ge; Lin Li; Zhiyun Jia
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

Review 9.  A Comprehensive Survey on the Detection, Classification, and Challenges of Neurological Disorders.

Authors:  Aklima Akter Lima; M Firoz Mridha; Sujoy Chandra Das; Muhammad Mohsin Kabir; Md Rashedul Islam; Yutaka Watanobe
Journal:  Biology (Basel)       Date:  2022-03-18

10.  [18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography.

Authors:  Gabriela Kramer-Marek; Dale O Kiesewetter; Lucia Martiniova; Elaine Jagoda; Sang Bong Lee; Jacek Capala
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-22       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.